Investigations on platelet/aneurysm interactions lead to $2.6 million NIH grant
Common cancer therapy increases serious risks in murine models
Our early experience shows lower-than-reported incidence, hints at role for neutrophilia
Consortium aims to reduce life-threatening side effect of therapy
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Mouse study shows most potent therapeutic ‘drugging’ of microbiome to date
A PI’s perspectives on ABSORB III interim results
Study raises prospect of new mechanism for preventing thrombotic events
Researchers see patient subgroups with higher clot risk
Drug-coated balloons, vascular brachytherapy, refining duration of dual antiplatelet therapy